# Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery

> **NCT01136590** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 96 (actual)

## Conditions studied

- Spinal Fusion
- Antifibrinolytic Agents
- Hemorrhage
- Blood Transfusion

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** fisiologic serum

## Key facts

- **NCT ID:** NCT01136590
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2015-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136590, "Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01136590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*